Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization
Drug Manufacturers - Specialty & Generic Stocks at a Glance
Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.
There are 79 Drug Manufacturers - Specialty & Generic industry stocks tracked by Wall St. Rank, worth a combined $371B.
The largest by market cap are Takeda Pharmaceutical (TAK) at $69B, Teva Pharmaceutical Industries (TEVA) at $49.7B and Haleon (HLN) at $40.4B.
Among institutional investors, Trulieve Cannabis (TRLV) drew the most net new fund positions in Q2 2026: 123 funds opened new positions, taking total fund holders up 121 (2,017%) quarter-over-quarter.
- Combined market cap: $371B across 79 stocks.
- Largest constituent: Takeda Pharmaceutical (TAK), $69B market cap.
- Most net new fund positions in Q2 2026: Trulieve Cannabis (TRLV), +121 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.